DHAC/Rituximab Regimen

Preferred Label : DHAC/Rituximab Regimen;

NCIt synonyms : Carboplatin/Cytarabine/Dexamethasone/Rituximab; Dexamethasone/High-dose Cytarabine/Carboplatin/Rituximab; Dexamethasone/High-dose Ara-C/Carboplatin/Rituximab; DHAC Plus Rituximab; Dexamethasone/Cytarabine/Carboplatin/Rituximab; Dexamethasone-Cytarabine-Carboplatin-Rituximab; Carboplatin-Cytarabine-Dexamethasone -Rituximab; DHAC-R;

NCIt definition : A regimen consisting of carboplatin, cytarabine, dexamethasone and rituximab that can be used for the treatment of diffuse large B-cell lymphoma and mantle cell lymphoma.;

NCI Metathesaurus CUI : CL1912834;

Details

Origin ID

C192836;

UMLS CUI

C5785455;

Semantic type(s)
- Therapeutic or Preventive Procedure [UMLS semantic type]
chemotherapy_regimen_has_component
- Carboplatin [NCIt concept]
- Cytarabine [NCIt concept]
- Dexamethasone [NCIt concept]
- Rituximab [NCIt concept]
concept_is_in_subset
- Multi-agent Therapeutic Regimens [NCIt concept]
- Pharmacotherapy Regimens [NCIt concept]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients